🇺🇸 FDA
Pipeline program

Colchicine (Colcrys®)

IL1T-GA-1103

Approved small_molecule completed

Quick answer

Colchicine (Colcrys®) for Intercritical Gout is a Approved program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
REGENERON PHARMACEUTICALS, INC.
Indication
Intercritical Gout
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials